|
PHARMA
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
May 22, 2009
Health: Need Of The Hour
Swine flu, which has infected more than 10,000 people worldwide, has now spread to India.
|
| |
May 08, 2009
Government To The Rescue
The commerce ministry will share costs with drug firms to fight customs at Amsterdam
|
| |
|
|
| |
|
|
| |
May 01, 2009
Not Immune
Financial crisis is hitting ‘recession-proof’ pharma firms too
|
| |
|
|
| |
April 10, 2009
Why The Secrecy?
India’s first clinical trial audit should be taken to its logical conclusion
|
| |
|
|
| |
|
|
| |
|
|
| |
March 20, 2009
A Bit Too Early To Cheer
Even if the US allows copies of biotech drugs, Indian firms will not get there soon
|
| |
March 13, 2009
The Second Wave
Mega deals in quick succession are rocking the global pharma industry...
|
| |
|
|
| |
|
|
| |
|
|
| |
Feb 20, 2009
No Quick Fixes
Past buys are proving to be costly for Wockhardt’s chairman in 2003, rumours swirled that habil...
|
| |
Feb 13, 2009
The Next Opportunity
US president Barack Obama’s pledge to support biosimilars may come as a blessing for Indian pharma firms. Generic versions of biotech drugs, for long...
|
| |
|
|
| |
|
|
| |
Feb 06, 2009
Intelligence And Death
Finally, we know that how intelligent we are and how long we shall live are caused by both environmental and genetic influences...
|
| |
Jan 30, 2009
Go Shopping
This is the best time for Indian drug makers to go in for global acquisitions...
|
| |
|
|
| |
Jan 09, 2009
Taro's Twist
Sun Pharma's quest to acquire Israel's Taro is getting longer
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Dec 19, 2008
Health Monitor: The HIV Scapegoats
Gender bias on HIV permeates across Africa, and it has been made worse
by a law that makes it easier for the carriers not to know
|
| |
Dec 12, 2008
Pharmaceuticals: Dose Of Death
Surendar, a 25-year-old who enrolled in a study to establish the similarity between two versions of widely used blood...
|
| |
|
|
| |
|
|
| |
Nov 28, 2008
Pharmaceuticals: Patenting Restrictions
The Public Funded R&D (Protection, Utilisation and Regulation of Intellectual Property) Bill, cleared recently by the Cabinet, mandates patenting of medical research.
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Oct 24, 2008
Changing Hands
India’s largest generic drug maker, Ranbaxy Laboratories, has finally become a subsidiary of Japanese firm Daiichi Sankyo, but...
|
| |
Oct 17, 2008
The Saga Of A Deal
Daiichi Sankyo is taking a major write-off on the Ranbaxy deal
|
| |
Oct 10, 2008
New Model
MNCs are now using joint ventures to outsource their work to India
|
| |
Oct 10, 2008
Bound By The Norms
Are the Singhs set to seal the Daiichi deal at a lower price?
|
| |
|
|
| |
|
|
| |
Aug 29, 2008
Entry Denied
Why the Indian government is lobbying with the US for Ranbaxy
|
| |
|
|
| |
|
|
| |
Aug 29, 2008
A Shot In The Arm
A court ruling may pave the way for Sun's Taro buy-out
|
| |
|
|
| |
|
|
| |
|
|
| |
July 25, 2008
Foreign Hand
The Drug Controller General of India (DCGI) wants to inspect pharma plants...
|
| |
July 25, 2008
Generic Appeasement
Out-of-court settlements by pharma majors come under scrutiny
|
| |
July 18, 2008
Talent Crunch: Flying Nightingales
As migration of nurses continues unchecked, hospitals are devising strategies to ensure their dreams of turning India into a worldwide medical hub doesn't sour, writes Chitra Narayanan.
|
| |
July 18, 2008
Ranbaxy's Pincer
Daiichi is unlikely to change its plan to acquire Ranbaxy
|
| |
July 4, 2008
Discounted Offer
Sun's move is unlikely to find favour with Taro shareholders
|
| |
July 4, 2008
Uneasy Access
Indian pharma companies rank low in access to medicines
|
| |
June 27, 2008
Master Dealmaker
A boutique advisory firm led the Daiichi-Ranbaxy deal
|
| |
|
|
| |
|
|
| |
June 13, 2008
Pharma: Arigato Daiichi!
The Japanese pharma major has bought out India’s largest drug maker Ranbaxy on generous terms. Here’s why, and what it will mean for India Inc.
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
May 01, 2008
Health Monitor: Controlling Cancer
Attacking known environmental carcinogens such as radiation, sunlight and benzene apart from tobacco is essential to curb cancer
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
March 07, 2008
Shot In The Arm
The German court ruling has given a temporary relief to Dr. Reddy's
|
| |
March 07, 2008
Ayurveda: Trouble Brewing
Ayurveda is caught between the purist and the experimenter |
| |
January 07, 2008
Beyond Generics
Indian pharma companies are hiving off R&D units into separate companies in their quest for new drugs.
|
| |
December 31, 2007
Pharma: Ayurveda Remix
Traditional ayurveda companies allege that the government is undermining the age-old science by expanding its definition.
|
| |
|
|
| |
December 3, 2007
Pharma: Desperate Remedies
The numbers must add up in a big way for organised pharma retail to enable better prices and genuine drugs
|
| |
|
|
| |
|
|
| |
October 22, 2007
Pharma: Few Takers
The injectible version of the polio vaccine fails to make much headway in India
|
| |
October 1, 2007
Health Insurance: Cover For All
In spite of privatisation and detariffing, the quality and spread of health insurance in India is far from satisfactory. What ails us?
|
| |
September 24, 2007
Pharma: Failing The Test
A boom in the country’s new drug trials industry has spawned schools that teach drug testing for a price. But employers find them wanting.
|
| |
September 24, 2007
The Side Effect
India’s copycat drug makers could benefit from the US tech industry’s push for patent reforms
|
| |
September 17, 2007
Healthcare: Register, Or Else...
A legislation critical for the health of every Indian has just been tabled in Parliament without public debate
|
| |
September 3, 2007
India Pharma 2015
McKinsey’s just released report on the Indian pharmaceutical market says the industry will treble in the next decade,...
|
| |
August 20, 2007
Pharma: The Dragon Slips Up
With policy changes in China affecting pharma manufacturing there, Indian companies may emerge winners
|
| |
August 6, 2007
Pharma: Caught In a Rigid Knot
India’s stringent narcotics control laws are depriving cancer patients of a potent, and cheap painkiller.
|
| |
July 30, 2007
Pharma: Paying The Price
Cheap access to key life-saving drugs is still a dream in India. But putting them on price control may not be the solution.
|
| |
July 2, 2007
Roughing It Out
How some mid-size pharma firms reinvented themselves to survive the patent regime and competition
|
| |
June 25, 2007
Taking On Big Pharma
Generic firms will benefit as Thailand and Brazil override patents, but India has much to learn about protecting public health
|
| |
June 18, 2007
A Window To Riches
Biotech upstart HiMedia Labs has ambitious plans to take on global R&D majors. Armed with a pioneer’s edge in vegetable peptones, the company has more than a fighting chance
|
| |
June 18, 2007
Information Central
How Akhilesh Pandey’s little- known Bangalore institute made a big difference to global computational biology research
|
| |
June, 2007
Just Lose It
A pop star, a reality show, a new pill. Noise levels on the battle of the bulge have just got louder.
|
| |
May 28, 2007
Asia Beckons
India and China look set to emerge as future growth engines for the global biotech industry.
|
| |
May 28, 2007
Large Dose
Mylan Labs’ purchase of Merck KGaA’s generics division will be a hard act to swallow.
|
| |
May 7, 2007
Cloning Success
India’s drugmakers are entering a market that so far has been multinational territory.
|
| |
April 23, 2007
Sticker Shock
Biotech copycats are discovering the real cost of going West. And it is not cheap.
|
| |
April 23, 2007
Déjà Vu
A proposed law on biotech copycats is the latest battleground for generic companies and innovators in the US.
|
| |
April 12, 2007
A Dose Of Hope
For Shantha Biotechnics, the deal with Merieux Alliance comes at the right time.
|
| |
February 12, 2007
The Patent Attack
India’s patent law is under the scanner after Novartis challenged it in court and the Mashelkar Committee found fault with it. But the domestic drugs industry is fighting back with global support
|
| |
January 15, 2007
The Makeover
Jubilant Biosys is trying to transform itself into a drug discovery services company, while strengthening its roots in bioinformatics
|
| |
January 08, 2007
Dark Horses
Ratan Tata and Big Pharma Merck have bet early on these men. Now Advinus Therapeutics, their brainchild, has to deliver
|
| |
| 2006 |
| |
December 18, 2006
Healthcare: The Corporate Push
Following pioneer Apollo, now Max, Fortis and Wockhardt are adding a new dimension to the private hospital industry
|
| |
December 04, 2006
Bucking the Trend
Indian pharma outsourcing companies are buying up high cost operations in the West. Is this a sound strategy?
|
| |
November 20, 2006
The New Drug Chain
Indian and small western companies are together creating a drug discovery ecosystem that can challenge the might of the Big Pharma one day
|
| |
September 11, 2006
The Matrix Revolution
In 2000, N. Prasad bought a company for Rs 3 crore. In August 2006, he sold it for a valuation of Rs 6,210 crore
|
| |
|
|
| |
July 17, 2006
Biogenerics
Indian Pharma’s Big Opportunity
|
| |
|
|
| |
April 03, 2006
Dr Reddy's Polypill: Blockbuster or Dud?
Hyderabad-based company is racing to become the first pharma company in the world to introduce the controversial multiple-product pill for heart ailments
|
| |
March 20, 2006
Eurocentric!
Dr Reddy's Labs has firmed up its European foray with the purchase of German generic company betapharm for $570 million
|
| |
| 2005 |
| |
|
|
| |
|
|
| |
|
|
| |
November 28, 2005
The Scramble for Tamiflu
Indian companies are ready with a generic version of the drug that fights the deadly bird flu virus. Will they take on the MNCs?
|
| |
|
|
| |
|
|
| |
Sensex rises 61 points in opening trade 
